Mouse Anti-LBX2 Recombinant Antibody (CBYJL-1245) (CBMAB-L0780-YJ)

Su, Y., Li, C., Fang, Y., Gu, X., Zheng, Q., Lu, J., & Li, L. (2023). The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility. Clinical and Translational Oncology, 25(2), 293-305.

Sun, C., Tuason, J. P. W., Bhan, C., Paudel, A., Ahmed, M. K., Kim, N. H., ... & Abid, Q. U. A. (2022). LBX2 expression and outcomes in patients with colon adenocarcinoma.

Xu, G., Zhang, Y., Li, N., Wu, Y., Zhang, J., Xu, R., & Ming, H. (2020). LBX2-AS1 up-regulated by NFIC boosts cell proliferation, migration and invasion in gastric cancer through targeting miR-491-5p/ZNF703. Cancer Cell International, 20(1), 1-11.

Li, H., Zhang, H., Wang, G., Chen, Z., & Pan, Y. (2020). LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop. Biomedicine & Pharmacotherapy, 129, 109904.

Hu, J., Bai, Y., Zhang, Q., Li, M., Yin, R., & Xu, L. (2020). Identification of LBX2 as a novel causal gene of lung adenocarcinoma. Thoracic Cancer, 11(8), 2137-2145.

Zhang, Y., Chen, W., Pan, T., Wang, H., Zhang, Y., & Li, C. (2019). LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs. Biochemical and biophysical research communications, 511(3), 566-572.

Wang, J., Luo, J., Chen, Q., Wang, X., He, J., Zhang, W., ... & Wang, B. (2018). Identification of LBX2 as a novel causal gene of atrial septal defect. International Journal of Cardiology, 265, 188-194.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols